Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells

Circulation

Volumn 94, Issue 6, 1996, Pages 1402-1407

  Kim Schulze, Seunghee ^a,f   McGowan, Kelly A ^b   Hubchak, Susan C ^a   Cid, Maria C ^c   Martin, Mary Beth ^d   Kleinman, Hynda K ^b   Greene, Geoffrey L ^e   Schnaper, H William ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c Fundacio Clinic   (Spain)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f Pediatrics W 140   (United States)

Author keywords

cells; endothelium; estrogen; receptors

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR;

ARTICLE; CELL PROLIFERATION; CORONARY ARTERY; ENDOTHELIUM CELL; GENE EXPRESSION; HEART PROTECTION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

EID: 0029822927     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.6.1402     Document Type: Article

References (38)

1. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-1110.
2. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 1991;325:756-762.
3. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17β-estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 1990;10:1051-1057.
4. Hough IL, Zilversmit DB. Effect of 17β-estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis. 1986;6:57-63.
5. Weigensberg BI, Lough J, More RH, Katz E, Pugash E, Peniston C. Effects of estradiol on myointimal thickenings from catheter injury and on organizing white non-occlusive thrombi. Atherosclerosis. 1984;52:253-265.
6. Sullivan TR, Karas RH, Arnovitz M, Faller GT, Ziar JP, Smith JJ, O'Donnell TF, Mendelsohn ME. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest. 1995;96;2482-2488.
7. Carson-Jurica MA, Schrader WT, O'Malley BW. Steroid receptor family: structure and functions. Endocrinol Rev. 1990;11:201-220.
8. Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988;240:889-895.
9. Thomas T, Thomas TJ. Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells. Cancer Res. 1994;54:1077-1084.
10. Harder DR, Coulson PB. Estrogen receptor and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J Cell Physiol. 1979;100:375-382.
11. McGill HC, Sheridan PJ. Nuclear uptake of sex steroid hormones in the cardiovascular system of the baboon. Circ Res. 1981;48:238-244.
12. Thomas ML, Xu X, Norfleet AM, Watson CS. The presence of functional estrogen receptors in intestinal epithelial cells. Endocrinology. 1993;132:426-430.
13. + channels in arterial smooth muscle. Science. 1989;245:177-180.
14. Brayden JE, Nelson MT, Regulation of arterial tone by activation of calcium-dependent potassium channels. Science. 1992;256:532-535.
15. Yallampalli C, Byam-Smith M, Nelson SO, Garfield RE. Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology. 1994;134:1971-1974.
16. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 1994;89:1501-1510.
17. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK, Schnaper HW. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation. 1995;91:755-763.
18. Thompson EW, Reich R, Shima TB, Albini A, Graf J, Martin GR, Dickson RB, Lippman ME. Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Res. 1988;48:6764-6768.
19. Williams FMK, Dosso AA, Kohner EM, Porta M. Pericyte mitogenic activity is reduced in the blood of type 1 diabetic patients with and without retinopathy. Acta Diabetol. 1993;30:123-127.
20. Greene GL, Sobel NB, King WJ, Jensen EV. Immunochemical studies of estrogen receptors. J Steroid Biochem. 1984;20:51-56.
21. Blaustein JD. Cytoplasmic estrogen receptors in rat brain: immunocytochemical evidence using three antibodies with distinct epitopes. Endocrinology, 1992;131:1336-1342.
22. Glisin V, Crkvenjakov C, Byus C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry. 1974;13:2633-2637.
23. Saceda M, Lippman ME, Chambon P, Lindsey RL, Ponglikitmongkol M, Puente M, Martin MB. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol. 1988;2:1157-1162.
24. Dimitrova D, Vassilev L, Anachkova B, Russev G, Isolation and cloning of putative mouse DNA replication initiation sites: binding to nuclear protein factors. Nucleic Acids Res. 1993;21:5554-5560.
25. Yamashita S, Newbold PR, McLachlan JA, Korach KS. The role of estrogen receptor in uterine epithelial proliferation and cytodifferentiation in neonatal mice. Endocrinology. 1990;127:2456-2463.
26. Lin AL, Gonzalez JR, Carey KD, Shain SA. Estradiol-17β affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arteriosclerosis, 1986;6:495-504.
27. Orimo A, Inoue S, Ikegami A, Hosoi T, Akishita A, Ouchi V, Muramatsu M, Orimo H. Vascular smooth muscle cells as target for estrogen. Biochem Biophys Res Commun. 1993;195:730-736.
28. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 1994;89:1943-1950.
29. Colburn P, Buonassisi V. Estrogen-binding sites in endothelial cell cultures. Science. 1978;201:817-819.
30. Brandi ML, Crescioli C, Tanini A, Frediani U, Agnusdei D, Gennari C. Bone endothelial cells as estrogen targets. Calcif Tissue Int. 1993;53;312-317.
31. Naftolin F, Tolis G. Neuroendocrine regulation of the menstrual cycle. Clin Obstet Gynecol. 1978;21:17-29.
32. Grandien K, Backdahl M, Ljunggren O, Gustafsson J-A, Berkenstam A. Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines. Endocrinology. 1995;136:2223-2229.
33. Furlow JD, Murdoch FE, Gorski J. High affinity binding of the estrogen receptor to a DNA response element does not require homo-dimer formation or estrogen. J Biol Chem. 1993;268:12519-12525.
34. Kumar V, Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell. 1988; 55:145-156.
35. Kerppola TK, Luk D, Curran T. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol Cell Biol. 1993;13:3782-3791.
36. Jonat C, Rahmsdorf HJ, Park K-K, Cato A, Gebel S, Ponta H, Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (fos/jun) activity by glucocorticoid hormone. Cell. 1990; 62:1189-1204.
37. Philips A, Chalbos D, Rochefort H. Estradiol increases and antiestrogens antagonize the growth factor-induced activator protein-1 activity in MCF-7 breast cancer cells without affecting c-fos and c-jun synthesis. J Biol Chem. 1993;268:14103-14108.
38. Halachmi S, Marden E, Martin G, Mackay H, Abbondanza C, Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science. 1994;264:1455-1458.